TrialLancet (London, England)2017

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Dilan Athauda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.